caspofungin for injection powder for solution
fresenius kabi canada ltd - caspofungin (caspofungin acetate) - powder for solution - 70mg - caspofungin (caspofungin acetate) 70mg - echinocandins
caspofungin teva pdr/conc/soln for infus 50mg
teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 mg - antimycotics for systemic use
caspofungin teva pdr/conc/soln for infus 70mg
teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 mg - antimycotics for systemic use
caspofungin clonmel 50 mg powder for concentrate for solution for infusion
clonmel healthcare ltd - caspofungin acetate - powder for concentrate for solution for infusion - 50 milligram(s) - caspofungin
caspofungin clonmel 70 mg powder for concentrate for solution for infusion
clonmel healthcare ltd - caspofungin acetate - powder for concentrate for solution for infusion - 70 milligram(s) - caspofungin
caspofungin clonmel 50mg powder for concentrate for solution for infusion
clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 mg - antimycotics for systemic use
caspofungin clonmel 70 mg powder for concentrate for solution for infusion
clonmel healthcare limited waterford road, clonmel, co. tipperary e91 d768, ireland - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 mg - antimycotics for systemic use
caspofungin myx caspofungin (as acetate) 70 mg powder for injection vial
mayne pharma international pty ltd - caspofungin -
caspofungin myx caspofungin (as acetate) 50 mg powder for injection vial
mayne pharma international pty ltd - caspofungin -
caspodas caspofungin (as acetate) 70mg powder for injection vial
medtas pty ltd - caspofungin acetate, quantity: 77.7 mg - injection, powder for - excipient ingredients: sucrose; mannitol; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - caspodas is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.